Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 迈得医疗——致力成为全球医用耗材自动化的领军者。 迈得医疗是医疗行业领先的医疗耗材自动化专家，致力于为客户提供智能制造系统性解决方案。 从研发制造医用耗材自动化生产线开始，时至今日迈得构建起智能装备、专业软件、工艺开发三大业务体系。 在迈得有超过700名来自世界不同国家，拥有不同专业背景和履历的员工，200余名技术专家从事各类研发工作。迈得自主研发的输液类管路、医用留置针、纺丝线、血液透析器智能生产线，获得了中国国家级创新荣誉。 我们先后为全球数百家客户定制了3000余项系统性解决方案。其中不乏费森尤斯·卡比、泰尔茂、山东威高、康德莱等中国乃至世界一流的医疗企业。 站在行业前沿的迈得将坚持深耕医疗，不断追求技术创新，为更多客户带来领先的智能装备和专业技术服务；使客户和迈得可以在合作中共同成长，推动整个医疗行业革新发展。
Main Business 医用耗材智能装备的研发、生产、销售和服务
Legal Representative 林军华
Top Executives
董事长：林军华
董事：刘学涛,林军华,林君辉,林栋
独立董事：张颖辉,何涛,王亚卡
Top 5 Shareholder
Shareholder name Nature Holding Date
林军华流通A股47.42%30/09/2024
陈万顺流通A股14.98%30/09/2024
台州赛纳投资咨询合伙企业（有限合伙）流通A股3.47%30/09/2024
华夏基金管理有限公司－社保基金四二二组合流通A股2.46%30/09/2024
中国银行股份有限公司－华夏行业景气混合型证券投资基金流通A股2.22%30/09/2024
Company Secretary 林栋
Solicitors 浙江天册律师事务所
Auditors 天健会计师事务所（特殊普通合伙）
Tel No 0576-87356888
Fax No 4008875666-107752
Website www.maiderchina.com
Email zq@maiderchina.com
Company Address
Register: 浙江省台州市玉环县沙门镇滨港工业城
Office: 浙江省台州市玉环县沙门镇滨港工业城
Listing Date 03/12/2019
Shares Capital
Shares Capital: 165,269,766
Total A Share: 165,269,766
Listed A Share: 165,269,766
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.850
DPS(RMB)* ¥ 0.500
NBV Per Share(RMB)* ¥ 7.572
Market Capitalization(RMB) 2.129B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.